← Back to news
June 23, 2026
White House Denies Trump Received Early Access to Experimental Obesity Drug
- Multiple White House officials denied that President Trump was the 79-year-old patient who received early access to the obesity drug retatrutide.
- The drug was reportedly provided under 'compassionate use' for severe health conditions, raising questions about the patient's connections.
- White House communications labeled the speculation as 'baseless' and 'falsehoods', emphasizing that it was not Trump.
2 Sources
- White House denies Trump is the ‘well-connected’ 79-year-old man who gained compassionate access to Eli Lilly obesity drug in AprilJun 23, 2026 at 8:50 PM · Independent
- White House bats down speculation that Trump got access to Eli Lilly obesity drug for ‘compassionate use’Jun 23, 2026 at 10:20 PM · The Hill